|
|
|
|
|
Home > CORPORATE ACTION
> Bse Announcements
|
|
|
|
As on 12-Mar-26
|
|
|
|
Amarjothi Spg. Mills
|
|
Inter alia, to consider the following :- 1. To consider the resignation of Company Secretary and Compliance Officer. 2. Other business matters
|
|
|
|
|
Chandan Healthcare
|
|
The Exchange had sought clarification from Chandan Healthcare Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
|
|
|
|
|
Damodar Inds.
|
|
Inter alia, to consider and approve:- l. To appoint Mr. Suresh Narayan Nayak (DIN: 11588687) as an additional director (Non-Executive Independent category) of the company. 2. To appoint any E-Voting agency for providing E-voting facility and related services in connection with Postal Ballot 3. To consider and approve the draft Notice of postal Ballot. 4. To authorize any director to conduct the postal ballot process and sign and send the Notice along with other Documents. 5. To decide and fix the cut-off date to determine eligibility of the shareholders who are entitled to receive notice ofpostal ballot and cast their vote. 6. To appoint Vishal N Manseta, Practicing Company Secretary as the Scrutinizer for the postal ballot process. 7. Any other item with permission of Chair.
|
|
|
|
|
Delaplex
|
|
Delaplex Limited has informed the Exchange regarding 'Disclosure under Regulation 29 (2) of Securities and Exchange Board of India (Substantial acquisition of Shares and Takeovers) Regulations, 2011'.
|
|
|
|
|
Electrost Castings
|
|
The Exchange has sought clarification from Electrosteel Castings Ltd on March 12, 2026, with reference to Movement in Volume. The reply is awaited.
|
|
|
|
|
Fert Chem Travancore
|
|
The Exchange has sought clarification from Fertilizers and Chemicals Travancore Ltd on March 12, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
|
|
|
|
|
Jagsonpal Pharma
|
|
Buy Back of Shares Inter alia considered and approved the proposal for buyback of equity shares of the Company in compliance with Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018 (SEBI Buyback Regulations), subject to approval of the shareholders and other applicable statutory approvals, as may be required. The details pertaining to proposed Buyback is as under 1. Upto 16,00,000 (16 lakhs) equity shares (representing 2.39% of the paid-up equity capital of the Company 2. Buy back Price : Rs. 250.00 per equity shares (Rupees Two Hundred and Fifty Only) 3. Maximum Buyback Offer size : Rs. 40,00,00,000 (Rupees Forty Crores only), representing 18.35% of the paid-up equity share capital and free reserves as per audited financial statements as at March 31, 2025 The Maximum Buyback Offer Size does not include expenses such as brokerage costs, fees, turnover charges, securities transaction tax, goods and services tax (if any), stamp duty, filing fees payable to SEBI, stock exchange charges, advisors? and legal fees, printing and dispatch expenses, public announcement publication expenses and other incidental and related expenses. Method of Buyback The Buyback will be undertaken through the ?tender offer? route on a proportionate basis in accordance with the provisions of the SEBI Buyback Regulations Other details: ? Centrum Capital Limited, a SEBI registered Merchant Banker, has been appointed as the Manager to the Buyback. ? The Board has constituted a ?Buyback Committee? and delegated necessary powers to it, including fixing the record date and undertaking actions in relation to the proposed Buyback. ? Mr. Pratham Rawal, Company Secretary & Compliance Officer, has been designated as the Compliance Officer for the Buyback. ? The Promoters/Promoter Group will not be participating in the proposed Buyback. ? Details of Postal ballot for seeking shareholder approval for the proposed Buyback will be intimated separately
|
|
|
|
|
Karnika Industries
|
|
The Exchange has sought clarification from Karnika Industries Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
|
|
|
|
|
Kore Digital
|
|
Kore Digital Limited has informed the Exchange regarding 'Kore Digital Enters India s Defense Manufacturing Ecosystem with Indian Air Force Vendor Approval'.
|
|
|
|
|
Kore Digital
|
|
Kore Digital Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2026.
|
|
|
|
|
Kundan Edifice
|
|
Kundan Edifice Limited has informed the Exchange regarding 'Kundan Edifice Ltd_Intimation under Regulation 30 Update on Vendor Registration Process with Hettich India Private Limited'.
|
|
|
|
|
M.v.k. Agro Foodprod
|
|
The Exchange has sought clarification from M.V.K. Agro Food Product Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
|
|
|
|
|
Master Components
|
|
Master Components Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2026.
|
|
|
|
|
Maxposure
|
|
Maxposure Limited has informed the Exchange regarding Board Comments on non-compliance/ delayed compliance and fine paid
|
|
|
|
|
Maxposure
|
|
Maxposure Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2026 regarding Appoitment of CEO and KMP of the Company and Change in Market Maker subject to necessary regulatory compliances
|
|
|
|
|
Maxposure
|
|
Maxposure Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2026 regarding Appoitment of CEO and KMP of the Company and Change in Market Maker subject to necessary regulatory compliances
|
|
|
|
|
Modernthreads
|
|
with reference to your clarification vide email L/SURV/ONL/PV/SJ/2025-2026/3426 dated 11th March, 2026, we hereby clarify that the Company has been complying with regulation 30 of the SEBI(LODR) Regulation 2015 and have from time to time made all necessary disclosure to the stock exchange within stipulated timeline.
|
|
|
|
|
Nbi Indl. Finance
|
|
N. B. I. Industrial Finance Company Limited has informed the Exchange about opening of a special window to facilitate transfer and dematerialization ( demat ) of physical securities which were sold / purchased prior to April 1st, 2019.
|
|
|
|
|
Nuvoco Vistas Corpor
|
|
The Exchange has sought clarification from Nuvoco Vistas Corporation Ltd on March 12, 2026, with reference to Movement in Volume. The reply is awaited.
|
|
|
|
|
Orient Bell
|
|
The Exchange has sought clarification from Orient Bell Ltd on March 12, 2026, with reference to news appeared in https://www.business-standard.com dated March 12, 2026 quoting "Orientbell Embarks on a Digital Logistics Transformation Journey with Traqo." The reply is awaited.
|
|
|
|
|
|
|
|
|
|
|